Paid Clinical Trials Rochester
Discover 450 paid clinical trials in Rochester, New York. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Sponsor:
National Cancer Institute (NCI)
Location:
Code:
NCT03866382
Conditions
Bladder Adenocarcinoma
Bladder Clear Cell Adenocarcinoma
Bladder Mixed Adenocarcinoma
Bladder Neuroendocrine Carcinoma
Bladder Small Cell Neuroendocrine Carcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Biospecimen Collection
Bone Scan
Cabozantinib S-malate
Computed Tomography
Echocardiography
Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in ER-Positive, HER-2 Positive Breast Cancers
Sponsor:
Ruth O'Regan
Location:
Code:
NCT04886531
Conditions
Breast Cancer
HER2-positive Breast Cancer
ER Positive Breast Cancer
PR-Positive Breast Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Neratinib
Letrozole (L) or Anastrozole (A)
Trastuzumab
Congenital Heart Disease GEnetic NEtwork Study (CHD GENES)
Sponsor:
Children's Hospital Medical Center, Cincinnati
Location:
Code:
NCT01196182
Conditions
Congenital Heart Defects
Eligibility Criteria
Sex: All
Age: 0 - 70+
Healthy Volunteers: Not accepted
A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
Sponsor:
Takeda
Location:
Code:
NCT04779320
Conditions
Crohn's Disease (CD)
Eligibility Criteria
Sex: All
Age: 2 - 17
Healthy Volunteers: Not accepted
Interventions
Vedolizumab IV
A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine
Sponsor:
Eli Lilly and Company
Location:
Code:
NCT04396574
Conditions
Migraine
Eligibility Criteria
Sex: All
Age: 6 - 17
Healthy Volunteers: Not accepted
Interventions
Lasmiditan
Effect of Testosterone Treatment on Embryo Quality
Sponsor:
Center for Human Reproduction
Location:
Code:
NCT01662466
Conditions
Primary Ovarian Insufficiency
Female Infertility Due to Diminished Ovarian Reserve
Eligibility Criteria
Sex: Female
Age: 38 - 44
Healthy Volunteers: Not accepted
Interventions
Testosterone cream (0.5mg per gram)
DHEA
Placebo
Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer
Sponsor:
Bayer
Location:
Code:
NCT04464226
Conditions
Cancer
Eligibility Criteria
Sex: Male
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Darolutamide (Nubeqa, BAY1841788)
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Sponsor:
NRG Oncology
Location:
Code:
NCT05879926
Conditions
Breast Cancer
Eligibility Criteria
Sex: Female
Age: 18 - 60
Healthy Volunteers: Not accepted
Interventions
Ovarian Function Suppression + Aromatase Inhibitor
Adjuvant Chemotherapy + Ovarian Function Suppression
Efficacy of the Dreem 3S Ambulatory Sleep Monitoring Device for the Evaluation of Narcolepsy
Sponsor:
Beacon Biosignals
Location:
Code:
NCT06531876
Conditions
Narcolepsy Type 1
Hypersomnia
Sleep Disorder
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Dreem 3S recording